Ketamine-assisted buprenorphine initiation: a pilot case series.
Addiction Science & Clinical Practice August 29, 2024 Lucinda A Grande, Tom Hutch, Keira Jack et al. 6 citations
Many people with opioid use disorder who stand to benefit from buprenorphine treatment are unwilling to initiate it due to experience with or fear of both spontaneous and buprenorphine-precipitated opioid withdrawal (BPOW). An effective means of minimizing withdrawal symptoms would reduce patient apprehensiveness, lowering the barrier to buprenorphine initiation. Ketamine, approved by the FDA...